全文获取类型
收费全文 | 14393篇 |
免费 | 650篇 |
国内免费 | 107篇 |
专业分类
耳鼻咽喉 | 224篇 |
儿科学 | 382篇 |
妇产科学 | 184篇 |
基础医学 | 2233篇 |
口腔科学 | 247篇 |
临床医学 | 801篇 |
内科学 | 3714篇 |
皮肤病学 | 338篇 |
神经病学 | 954篇 |
特种医学 | 495篇 |
外科学 | 2490篇 |
综合类 | 51篇 |
预防医学 | 329篇 |
眼科学 | 168篇 |
药学 | 870篇 |
中国医学 | 34篇 |
肿瘤学 | 1636篇 |
出版年
2023年 | 51篇 |
2022年 | 114篇 |
2021年 | 292篇 |
2020年 | 149篇 |
2019年 | 191篇 |
2018年 | 246篇 |
2017年 | 214篇 |
2016年 | 269篇 |
2015年 | 242篇 |
2014年 | 352篇 |
2013年 | 421篇 |
2012年 | 724篇 |
2011年 | 823篇 |
2010年 | 471篇 |
2009年 | 399篇 |
2008年 | 700篇 |
2007年 | 818篇 |
2006年 | 836篇 |
2005年 | 828篇 |
2004年 | 852篇 |
2003年 | 841篇 |
2002年 | 913篇 |
2001年 | 440篇 |
2000年 | 396篇 |
1999年 | 373篇 |
1998年 | 240篇 |
1997年 | 195篇 |
1996年 | 169篇 |
1995年 | 133篇 |
1994年 | 138篇 |
1993年 | 153篇 |
1992年 | 225篇 |
1991年 | 207篇 |
1990年 | 198篇 |
1989年 | 181篇 |
1988年 | 144篇 |
1987年 | 133篇 |
1986年 | 121篇 |
1985年 | 114篇 |
1984年 | 86篇 |
1983年 | 65篇 |
1982年 | 51篇 |
1981年 | 42篇 |
1980年 | 52篇 |
1979年 | 69篇 |
1978年 | 55篇 |
1977年 | 41篇 |
1976年 | 38篇 |
1973年 | 46篇 |
1972年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
A case of bullous pemphigoid associated with psoriasis vulgaris showing Hailey–Hailey disease‐like histopathological changes in regenerated epidermis without genomic mutation in ATP2C1 or ATP2A2 gene 下载免费PDF全文
3.
Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers 下载免费PDF全文
4.
5.
Heterozygous nonsense mutations near the C‐terminal region of IGF1R in two patients with small‐for‐gestational‐age‐related short stature 下载免费PDF全文
6.
7.
8.
Shiro Akinaga Tadashi Ashizawa Katsushige Gomi Hiroe Ohno Makoto Morimoto Chikara Murakata Masami Okabe 《Cancer chemotherapy and pharmacology》1992,29(4):266-272
Summary Novel derivatives of K-252a, (8R*,9S*,11S*)-(–)-9-hydroxy-9-methoxycarbonyl-8-methyl-2,3,9,10-tetrahydro-8, 11-epoxy-1H,8H,11H-2,7b,11a-triazadibenzo [a,g]-cycloocta[cde]trinden-1-one, an inhibitor of protein kinases and calmodulin-dependent phosphodiesterase, were synthesized and evaluated for their antitumor activity in vitro and in vivo. Of ten derivatives tested, four were active against the P388 murine leukemia i. p.-i. p. system, although K-252a was inactive. Among these derivatives, KT6124 was selected for further biological evaluation studies because its efficacy was the highest. KT6124 was also active against sarcoma 180 and B16 melanoma. It exerted a relatively broad spectrum of antiproliferative activity against 20 human tumor cell lines in vitro. To determine the mechanism(s) of action underlying the antitumor activity of KT6124, we tested the drug for inhibition of protein kinases, including Ca2+-and phospholipid-dependent protein kinase (PKC), in intact A431 human epidermoid carcinoma cells in comparison with the PKC-inhibitory activity of K-252a. KT6124 did not antagonize the action of phorbol 12-myristate 13-acetate (PMA) in A431 cells, whereas K-252a did, suggesting that KT6124 may not act on protein kinases in the cells. The interaction of KT6124 with DNA in living cells was examined by the alkaline elution method. KT6124 apparantly exhibited DNA scission both dose-and time-dependently in the target cells. The DNA breakage was dependent on proteinase K treatment, suggesting its possible interaction with DNA-related enzyme(s). These results indicate that KT6124 exerts antitumor activity by acting on DNA or on DNA-related enzyme(s) in tumor cells rather than via the inhibition of protein kinases. 相似文献
9.